Published in J Immunol on June 19, 2015
Defective Signaling in the JAK-STAT Pathway Tracks with Chronic Inflammation and Cardiovascular Risk in Aging Humans. Cell Syst (2016) 0.84
The life cycle of a T cell after vaccination - where does immune ageing strike? Clin Exp Immunol (2016) 0.82
Immunosenescence: the Role of Aging in the Predisposition to Neuro-Infectious Complications Arising from the Treatment of Multiple Sclerosis. Curr Neurol Neurosci Rep (2017) 0.76
Modeling the dynamics of neonatal CD8(+) T-cell responses. Immunol Cell Biol (2016) 0.76
Successful and Maladaptive T Cell Aging. Immunity (2017) 0.75
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc (2009) 137.99
Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res (2008) 54.83
Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA (2003) 31.71
A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med (2005) 17.06
Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet (2003) 13.79
Effectiveness of influenza vaccine in the community-dwelling elderly. N Engl J Med (2007) 7.29
CD69 acts downstream of interferon-alpha/beta to inhibit S1P1 and lymphocyte egress from lymphoid organs. Nature (2006) 7.17
SOCS proteins, cytokine signalling and immune regulation. Nat Rev Immunol (2007) 6.89
Type I interferons act directly on CD8 T cells to allow clonal expansion and memory formation in response to viral infection. J Exp Med (2005) 6.59
Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon. Nat Immunol (2003) 5.36
Type i interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo. Immunity (2001) 5.04
Type I interferon: friend or foe? J Exp Med (2010) 4.40
The influence of age on T cell generation and TCR diversity. J Immunol (2005) 4.36
Aging of the immune system: how much can the adaptive immune system adapt? Immunity (2006) 4.30
Type I interferons keep activated T cells alive. J Exp Med (1999) 3.98
Interferon signalling network in innate defence. Cell Microbiol (2006) 3.90
The many important facets of T-cell repertoire diversity. Nat Rev Immunol (2004) 3.83
Regulation of type I interferon responses. Nat Rev Immunol (2014) 3.60
Age-associated decline in T cell repertoire diversity leads to holes in the repertoire and impaired immunity to influenza virus. J Exp Med (2008) 3.15
Critical role for STAT4 activation by type 1 interferons in the interferon-gamma response to viral infection. Science (2002) 3.05
West Nile virus: review of the literature. JAMA (2013) 2.79
Type I interferon as a powerful adjuvant for monocyte-derived dendritic cell development and activity in vitro and in Hu-PBL-SCID mice. J Exp Med (2000) 2.69
PIAS1 selectively inhibits interferon-inducible genes and is important in innate immunity. Nat Immunol (2004) 2.52
Safety and immunogenicity of a high dosage trivalent influenza vaccine among elderly subjects. Vaccine (2007) 2.51
Maintenance of peripheral naive T cells is sustained by thymus output in mice but not humans. Immunity (2012) 2.41
Adjuvanted H5N1 vaccine induces early CD4+ T cell response that predicts long-term persistence of protective antibody levels. Proc Natl Acad Sci U S A (2009) 2.41
Cutting edge: enhancement of antibody responses through direct stimulation of B and T cells by type I IFN. J Immunol (2006) 2.38
Vaccines with MF59 adjuvant expand the antibody repertoire to target protective sites of pandemic avian H5N1 influenza virus. Sci Transl Med (2010) 2.21
Decline in miR-181a expression with age impairs T cell receptor sensitivity by increasing DUSP6 activity. Nat Med (2012) 2.19
Type I interferons (IFNs) regulate tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) expression on human T cells: A novel mechanism for the antitumor effects of type I IFNs. J Exp Med (1999) 2.13
Inhibitors of cytokine signal transduction. J Biol Chem (2003) 2.10
Understanding immunosenescence to improve responses to vaccines. Nat Immunol (2013) 2.09
Influenza vaccine immunology. Immunol Rev (2011) 2.02
Interferon-alpha activates multiple STAT proteins and upregulates proliferation-associated IL-2Ralpha, c-myc, and pim-1 genes in human T cells. Blood (1999) 1.97
Shp-2 tyrosine phosphatase functions as a negative regulator of the interferon-stimulated Jak/STAT pathway. Mol Cell Biol (1999) 1.93
Immunosenescence: deficits in adaptive immunity in the elderly. Tissue Antigens (2007) 1.91
Differential regulation of the alpha/beta interferon-stimulated Jak/Stat pathway by the SH2 domain-containing tyrosine phosphatase SHPTP1. Mol Cell Biol (1995) 1.83
Immunosenescence: role and measurement in influenza vaccine response among the elderly. Vaccine (2007) 1.78
The neglected role of type I interferon in the T-cell response: implications for its clinical use. Immunol Today (1996) 1.63
Diversity and clonal selection in the human T-cell repertoire. Proc Natl Acad Sci U S A (2014) 1.63
Cutting edge: role of STAT1, STAT3, and STAT5 in IFN-alpha beta responses in T lymphocytes. J Immunol (2005) 1.57
Putting out the fire: coordinated suppression of the innate and adaptive immune systems by SOCS1 and SOCS3 proteins. Immunol Rev (2008) 1.53
Key role of T cell defects in age-related vulnerability to West Nile virus. J Exp Med (2009) 1.50
Causes, consequences, and reversal of immune system aging. J Clin Invest (2013) 1.50
Loss of naive T cells and repertoire constriction predict poor response to vaccination in old primates. J Immunol (2010) 1.41
The regulation of inflammation by interferons and their STATs. JAKSTAT (2013) 1.35
Risk factors for West Nile virus neuroinvasive disease, California, 2005. Emerg Infect Dis (2007) 1.33
Age-related increases in PGD(2) expression impair respiratory DC migration, resulting in diminished T cell responses upon respiratory virus infection in mice. J Clin Invest (2011) 1.32
Aging of the T cell compartment in mice and humans: from no naive expectations to foggy memories. J Immunol (2014) 1.31
PIAS proteins promote SUMO-1 conjugation to STAT1. Blood (2003) 1.29
IFN-alpha-induced signal transduction, gene expression, and antitumor activity of immune effector cells are negatively regulated by suppressor of cytokine signaling proteins. J Immunol (2007) 1.23
Modulation of T-cell function by type I interferon. Immunol Cell Biol (2012) 1.21
Suppressor of cytokine signaling (SOCS) 1 inhibits type I interferon (IFN) signaling via the interferon alpha receptor (IFNAR1)-associated tyrosine kinase Tyk2. J Biol Chem (2011) 1.17
Down-modulation of responses to type I IFN upon T cell activation. J Immunol (2003) 1.17
Mouse-passaged severe acute respiratory syndrome-associated coronavirus leads to lethal pulmonary edema and diffuse alveolar damage in adult but not young mice. Am J Pathol (2008) 1.12
Peripheral selection rather than thymic involution explains sudden contraction in naive CD4 T-cell diversity with age. Proc Natl Acad Sci U S A (2012) 1.11
Signal inhibition by the dual-specific phosphatase 4 impairs T cell-dependent B-cell responses with age. Proc Natl Acad Sci U S A (2012) 1.08
Tumor suppressor mechanisms in immune aging. Curr Opin Immunol (2009) 1.08
Type I interferon upregulates Bak and contributes to T cell loss during human immunodeficiency virus (HIV) infection. PLoS Pathog (2013) 1.04
Naive T cell maintenance and function in human aging. J Immunol (2015) 1.02
Aged-related shifts in T cell homeostasis lead to intrinsic T cell defects. Semin Immunol (2012) 1.01
The gracefully aging immune system. Sci Transl Med (2013) 0.99
Inhibition of IFN-alpha signaling by a PKC- and protein tyrosine phosphatase SHP-2-dependent pathway. Proc Natl Acad Sci U S A (2005) 0.98
CD4 T cell defects in the aged: causes, consequences and strategies to circumvent. Exp Gerontol (2014) 0.95
Involvement of TRAIL/TRAIL-R interaction in IFN-alpha-induced apoptosis of Daudi B lymphoma cells. Cytokine (2001) 0.93
Age-related Deficiencies in Antigen-Specific CD4 T cell Responses: Lessons from Mouse Models. Aging Dis (2011) 0.92
Type 1 IFN maintains the survival of anergic CD4+ T cells. J Immunol (2000) 0.92
Changing partners at the dance: Variations in STAT concentrations for shaping cytokine function and immune responses to viral infections. JAKSTAT (2013) 0.92
Type I interferons as vaccine adjuvants against infectious diseases and cancer. Expert Rev Vaccines (2008) 0.91
Age-dependent signature of metallothionein expression in primary CD4 T cell responses is due to sustained zinc signaling. Rejuvenation Res (2008) 0.89
Systems biology of vaccination in the elderly. Curr Top Microbiol Immunol (2013) 0.88
Mechanisms shaping the naïve T cell repertoire in the elderly - thymic involution or peripheral homeostatic proliferation? Exp Gerontol (2014) 0.87
T cells from elderly persons respond to neoantigenic stimulation with an unimpaired IL-2 production and an enhanced differentiation into effector cells. Exp Gerontol (2004) 0.83
IFN-alpha 2b reduces IL-2 production and IL-2 receptor function in primary CD4+ T cells. J Immunol (2000) 0.83
Interferon-beta-induced activation of c-Jun NH2-terminal kinase mediates apoptosis through up-regulation of CD95 in CH31 B lymphoma cells. Exp Cell Res (2004) 0.81
Perspectives on vaccine development for the elderly. Curr Opin Immunol (2013) 0.77